𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preoperative plasma levels of transforming growth factor β1 strongly predict clinical outcome in patients with bladder carcinoma

✍ Scribed by Shahrokh F. Shariat; Ja-Hong Kim; Ben Andrews; Michael W. Kattan; Thomas M. Wheeler; Isaac Y. Kim; Seth P. Lerner; Kevin M. Slawin

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
93 KB
Volume
92
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma transforming growth factor-β1 lev
Plasma transforming growth factor-β1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma
✍ Fengming Kong; Randy L. Jirtle; Dale H. Huang; Robert W. Clough; Mitchell S. Ans 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB 👁 1 views

## BACKGROUND. Plasma transforming growth factor-␤1 (TGF␤1) levels are increased in many malignancies at the time of diagnosis, including all forms of lung carcinoma. Therefore, the potential use of TGF␤1 as a plasma marker to predict the long term outcome of lung carcinoma patients treated with r

Elevated serum levels of transforming gr
Elevated serum levels of transforming growth factor β1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients
✍ Jingwu Xu; José Menezes; U. Prasad; Ali Ahmad 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 92 KB 👁 1 views

Nasopharyngeal carcinomas (NPCs) of non-keratinizing type are strongly associated with Epstein-Barr virus (EBV). EBV and its gene products induce the synthesis and/or release of transforming growth factor ␤1 (TGF-␤1) from human cells and platelets. TGF-␤1 is an immunosuppressive cytokine, and many t

Elevated serum levels of transforming gr
Elevated serum levels of transforming growth factor-β1 in patients with colorectal carcinoma : Its association with tumor progression and its significant decrease after curative surgical resection
✍ Kang Sup Shim; Kwang Ho Kim; Woon Sup Han; Eung Bum Park 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 1 views

## Background: Transforming growth factor-beta1 (tgf-beta1) acts as a potent inhibitor of cell growth and tumor progression but loss of this negative regulation can contribute to tumor development. some studies have reported an association between disease progression and tgf-beta1 expression in pat